Mohamed A O, Jansson A, Ronquist G
Department of Clinical Chemistry, Uppsala University, University Hospital, Sweden.
Scand J Clin Lab Invest. 1993 Nov;53(7):701-4. doi: 10.3109/00365519309092574.
Fifty-nine patients with homozygous sickle cell anaemia, 17 heterozygous individuals and 22 controls were investigated in respect to serum (S) 5'nucleotidase (5'NT, EC 3.1.3.5). The patients showed a significantly higher mean value of S-5'NT compared to the controls. However, this rise was heterogeneous as it occurred only among a subgroup of patients. The heterozygous individuals were not different from either the patients or the controls generating a situation which puts the heterozygous individuals in an intermediate position between the patients and the controls. S-5'NT showed significant correlation with S-bilirubin, S-aspartate aminotransferase, S-alanine aminotransferase and especially S-gammaglutamyl transferase. However, it was not correlated with S-alkaline phosphatase, which is another marker for hepatobiliary disease. These results suggest that the liver involvement in a subgroup of patients with sickle cell anaemia is a mixture of hepatocyte damage and the biliary tree involvement.
对59例纯合子镰状细胞贫血患者、17例杂合子个体和22例对照者的血清(S)5'-核苷酸酶(5'NT,EC 3.1.3.5)进行了研究。与对照组相比,患者的S-5'NT平均值显著更高。然而,这种升高是异质性的,因为它仅发生在一部分患者中。杂合子个体与患者或对照组均无差异,形成了一种使杂合子个体处于患者和对照组之间中间位置的情况。S-5'NT与S-胆红素、S-天冬氨酸转氨酶、S-丙氨酸转氨酶尤其是S-γ-谷氨酰转移酶显著相关。然而,它与S-碱性磷酸酶无关,S-碱性磷酸酶是肝胆疾病的另一个标志物。这些结果表明,镰状细胞贫血患者亚组中的肝脏受累是肝细胞损伤和胆道受累的混合情况。